MedPath

Investigating the success rate of using human acellular tissue in reconstructive surgeries in women with anterior or apical pelvic prolapse

Not Applicable
Conditions
pelvic prolapse.
Female genital prolapse
Registration Number
IRCT20180409039247N5
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
60
Inclusion Criteria

Women over 18 years of age
Patients with prolapse of the anterior and/or apical compartment stage 2 and above, which has caused complaints including the feeling of engorgement, mass discharge, and urination disorders.
candidate for reconstructive surgery

Exclusion Criteria

History of pelvic floor reconstruction surgery and urinary incontinence surgery
Uncontrolled diabetes
Any vaginal or abdominal surgery requires the use of mesh
Immunity deficiency or high dose corticosteroid use
Smoking or using hookah

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome: surgical success, 12 months after surgery, absence of prolapse beyond hymen in any compartment. Timepoint: before the intervention and 12 months after the intervention. Method of measurement: standard pelvic organ prolapse measurement system (POPQ).
Secondary Outcome Measures
NameTimeMethod
PFDI20 questionnaire. Timepoint: before and 12 months after intervention. Method of measurement: Questionnaire score, This questionnaire has three parts: intestinal (CRAD-8), bladder (UDI-6) and pelvic (PODI-6) symptoms. Each question in each part has a score between 0-4. 0 means no complaint and 4 means it is extremely uncomfortable. The items of each comparison will be added, multiplied by 25 and divided by the number of questions. Therefore, the score of each part will be between 0-100.
© Copyright 2025. All Rights Reserved by MedPath